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The role of pattern 
electroretinograms and optical 
coherence tomography 
angiography in the diagnosis 
of normal‑tension glaucoma
Sang Yeop Lee1,2*, Nak‑Hoon Son1,3, Hyoung Won Bae2, Gong Je Seong2 & Chan Yun Kim2
In this study, we investigated the correlation between pattern electroretinogram (PERG) and optical 
coherence tomography angiography (OCTA) parameters for diagnosis in patients with normal‑tension 
glaucoma (NTG). Forty‑nine normal individuals (49 eyes) and 60 patients with NTG (60 eyes) were 
enrolled. OCTA and PERG parameters, such as macular vessel density (VD) and the amplitude of N35–
P50 and P50–N95, were measured. Correlation analyses were performed between the parameters, 
and the area under the curve (AUC) was used to identify their diagnostic ability for NTG. Macular 
VD and the amplitude of N35–P50 and P50–N95 showed significant differences between the normal 
individuals and patients with NTG. Correlation between P50 and N95 amplitude and macular VD was 
significant in the normal and early glaucoma groups. Macular VD showed a higher AUC value (0.730) 
than that of P50–N95 amplitude (0.645) in the early glaucoma group. In the moderate to severe 
glaucoma group, the AUC value of the amplitude of P50–N95 (0.907) was higher than that of macular 
VD (0.876). The results indicate that PERG and OCTA parameters may identify glaucoma in its early 
stage, based on the severity of glaucomatous damage in patients with NTG.
Pattern electroretinogram (PERG) is a test for evaluating the electrical signals generated in the retina when a 
patterned stimulus of a certain luminance is applied. PERG can confirm macular retinal ganglion cell (RGC) 
dysfunction; therefore, it can be used for the diagnosis and prognosis of conditions with impaired function of 
the RGCs, such as glaucoma. In the past, several studies have demonstrated the utility of PERG in the diagnosis 
of  glaucoma1–6. Further, its utility in identifying early alteration of RGC function in patients with glaucoma is 
supported by various previous studies, indicating changes in the parameters related to PERG before visual func-
tion  changes7–9 and following reduction of intraocular pressure (IOP)10.
Optical coherence tomography angiography (OCTA), a recently developed imaging modality, is used for 
observing the microcirculation in the peripapillary or macular areas. Several studies have reported that in 
patients with glaucoma, OCTA may have a diagnostic ability comparable to that of optical coherence tomography 
(OCT)11–13. Moreover, some studies have identified a stronger association of OCTA with the visual function in 
comparison to  OCT14,15. Further, according to earlier studies, the vessel density (VD) and flow index of OCTA 
were decreased in patients with pre-perimetric  glaucoma14,16,17; hence, the utility of OCTA in confirming early 
glaucomatous changes may increase. OCT and the visual field (VF) test remain the most common methods 
of evaluating glaucomatous optic nerve damage in clinical practice. However, PERG and OCTA may play an 
important role in the evaluation of glaucomatous optic nerve damage in the future. Few studies have investi-
gated the correlations between PERG and OCTA parameters, and their role in the diagnosis of  glaucoma18,19. 
In addition, there are no studies that have verified the role and correlation of these two parameters in patients 
with normal-tension glaucoma (NTG). Since it is known that PERG responses are affected by  IOP20,21, further 
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studies are needed to verify the correlation between PERG and OCTA parameters and diagnostic abilities of 
these parameters in patients with NTG.
Therefore, in this study, we aimed to explore the relationship between PERG and OCTA parameters for diag-
nosis in patients with NTG. Further, besides verifying the individual diagnostic abilities of PERG and OCTA 
parameters, we also evaluated the changes in their diagnostic ability in evaluating glaucomatous functional and 
structural alterations by combining them with conventional methods.
Results
In total, 109 patients (49 eyes of 49 normal individuals and 60 eyes of 60 patients with NTG) were included in 
this study. Table 1 presents the comparison among the groups. Between the normal and the all-glaucoma group, 
there were significant differences in age, mean deviation (MD), pattern standard deviation (PSD), visual field 
index (VFI), central sensitivity, ganglion cell-inner plexiform layer (GC-IPL) average thickness, and macular 
VD. Among the PERG parameters, only the amplitude parameters (N35–P50 and P50–N95) showed significant 
differences. The sub-group comparison between the normal, early, and moderate to severe groups also revealed 
significant differences in the variables that were found to be different between the normal and the all-glaucoma 
group. The results of post hoc analyses are presented in Table 1. Among the PERG parameters, only the amplitude 
of P50–N95 showed significant differences on sub-group analyses.
Correlation analyses. As the amplitude of P50–N95 was the only significantly different PERG parameter 
on sub-group analyses, we conducted an age-adjusted correlation analysis between the amplitude of P50–N95 
and other parameters for glaucoma evaluation such as IOP, MD, central sensitivity, the amplitude of N35–P50, 
GC-IPL average thickness, and macular VD (Table 2).
Table 3 shows the results of age-adjusted correlation analysis between the macular VD and other parameters 
such as IOP, MD, central sensitivity, the amplitude of N35–P50, the amplitude of P50–N95, and GC-IPL aver-
age thickness. The results indicated a significant correlation between the amplitude of P50–N95 and macular 
VD in the normal and early NTG groups. The amplitude of P50–N95 showed a significant correlation with MD 
and central sensitivity in the early and moderate to severe NTG groups. However, the macular VD was not 
Table 1.  Comparison of demographics and clinical characteristics between normal and patients with NTG. 
Data are presented as mean ± SD or ratio. NTG normal-tension glaucoma, CCT central corneal thickness, 
GC-IPL ganglion cell-inner plexiform layer, IOP intraocular pressure, MD mean deviation, PSD pattern 
standard deviation, VFI visual field index. a Independent t-test or chi-square test between the normal and 
all-glaucoma groups. b Analysis of variance or chi-squared test in the normal, early, and moderate to severe 
glaucoma groups. c–e p1, p2, and p3 show the results of the post hoc analyses. cp1: normal vs. early glaucoma, 
dp2: normal vs. moderate to severe glaucoma, ep3: early glaucoma vs. moderate to severe glaucoma. *p < 0.05.
Normal 
(N = 49)
NTG (N = 60)




Age (years) 48.67 ± 16.01 55.13 ± 15.21 49.38 ± 16.11 60.52 ± 12.28 0.034* 0.002* 0.978 0.003* 0.014*
Sex (M:F) 29:20 34:26 16:13 18:15 0.847 0.624
CCT (mm) 550.9 ± 49.61 548.8 ± 47.92 554.76 ± 53.97 543.19 ± 43.61 0.820 0.640
Axial length 
(mm) 24.64 ± 1.22 25.07 ± 1.77 25.46 ± 1.53 24.71 ± 1.92 0.148 0.059
IOP (mmHg) 15.47 ± 3.48 15.62 ± 3.03 14.94 ± 3.36 16.34 ± 2.49 0.814 0.234
MD (dB) − 0.74 ± 0.84 − 7.28 ± 6.37 − 2.06 ± 1.71 − 12.17 ± 5.08  < 0.001*  < 0.001* 0.132  < 0.001*  < 0.001*
PSD (dB) 1.56 ± 0.42 6.32 ± 4.57 2.47 ± 1.95 9.92 ± 3.13  < 0.001*  < 0.001* 0.124  < 0.001*  < 0.001*
VFI (%) 98.69 ± 2.33 82.82 ± 18.28 96.76 ± 4.17 69.77 ± 16.66  < 0.001*  < 0.001* 0.646  < 0.001*  < 0.001*
Central sensi-








16.67 ± 2.24 12.95 ± 3.76 13.81 ± 3.68 12.15 ± 3.72  < 0.001*  < 0.001*  < 0.001*  < 0.001* 0.103
Latency (ms)
N35 22.68 ± 5.07 22.38 ± 7.58 22.16 ± 5.78 22.59 ± 9.08 0.812 0.942
P50 50.81 ± 3.83 50.05 ± 5.02 48.93 ± 4.48 51.1 ± 5.34 0.383 0.121
N95 96.51 ± 8.59 100.6 ± 16.73 98.07 ± 20.64 102.94 ± 11.87 0.125 0.120
Amplitude (μV)
N35–P50 3.02 ± 0.95 2.21 ± 1.14 2.43 ± 1.26 2.01 ± 0.99  < 0.001*  < 0.001* 0.048*  < 0.001* 0.262
P50–N95 5.19 ± 1.14 3.71 ± 1.43 4.56 ± 1.19 2.91 ± 1.15  < 0.001*  < 0.001* 0.039*  < 0.001*  < 0.001*
3
Vol.:(0123456789)
Scientific Reports |        (2021) 11:12257  | https://doi.org/10.1038/s41598-021-91813-z
www.nature.com/scientificreports/
significantly correlated with MD and central sensitivity. As for the GC-IPL average thickness, the amplitude of 
P50–N95 showed a significant correlation in all sub-groups. However, macular VD showed a significant cor-
relation only in the early NTG group.
Ability for glaucoma detection. We investigated the age-adjusted glaucoma detection ability of MD, 
average GC-IPL thickness, the amplitude of P50–N95, and macular VD. Figure 1 shows the receiver operating 
characteristic (ROC) curves for each method of glaucoma detection in various sub-groups. MD and average 
GC-IPL thickness showed a good ability for glaucoma detection in the normal group and the all-glaucoma 
group, with area under the curve (AUC) values of 0.880 and 0.896, respectively. The amplitude of P50–N95 had 
the lowest AUC value for glaucoma detection (AUC = 0.772). The order of AUC values for each method (average 
GC-IPL thickness > MD > macular VD > amplitude of P50–N95) was the same when investigating their ability 
for early glaucoma detection. Based on the AUC values, significant differences were observed in the ability to 
detect glaucoma between the amplitude of P50–N95 and MD (p = 0.021), the amplitude of P50–N95 and GC-IPL 
thickness (p = 0.003), and macular VD and GC-IPL thickness (p = 0.047). While detecting early glaucoma, the 
AUC value for GC-IPL thickness differed significantly from the amplitude of P50–N95 (p < 0.001) and macular 
VD (p = 0.034). In the moderate to severe glaucoma group, all methods showed AUC values of > 0.8, and the 
AUC value for the amplitude of P50–N95 (0.907) was higher than that of the macular VD (0.876). In addition, 
except for differences in the AUC values between the MD and other variables (MD vs. GC-IPL average thick-
ness, p = 0.037; MD vs. amplitude of P50-N95, p = 0.008; and MD vs. macular VD, p = 0.001), the AUC values 
of no other parameter for detecting glaucoma differed significantly in the moderate to severe glaucoma group.
By setting the glaucoma detection ability of the MD and average GC-IPL thickness as the reference, we 
evaluated the additional effects of PERG and OCTA in detecting glaucoma. The diagnostic ability was also 
calculated by considering the amplitude of P50–N95 and macular VD separately and in combination (Table 4). 
In all cases, the diagnostic ability was better when compared to the use of the reference method alone, but there 
were no statistically significant differences. The diagnostic ability for glaucoma was better when the amplitude of 
P50–N95 was added to the reference than when the macular VD was added. However, the difference was small 
and non-significant. Since the AUC value of the reference for moderate to severe glaucoma was 1, the results of 
the additional diagnostic ability for moderate to severe glaucoma are not presented in the Table 4.
Table 2.  Age-adjusted correlation analysis between the amplitude of P50–N95 and other parameters for 
glaucoma evaluation in the normal, early, and moderate to severe NTG groups. CI confidence interval, IOP 
intraocular pressure, MD mean deviation, GC-IPL ganglion cell-inner plexiform layer. *p < 0.05.
Normal Early Moderate to severe
β (95% CI) p β (95% CI) p β (95% CI) p
IOP (mmHg) 0.025 (− 0.091 to 0.142) 0.665  − 0.033 (− 0.212 to 0.145) 0.705  − 0.019 (− 0.158 to 0.120) 0.785
MD (dB) 0.214 (− 0.231 to 0.658) 0.338 0.345 (0.113 to 0.578) 0.005* 0.086 (0.002 to 0.170) 0.044*
Central sensitivity (dB) 0.205 (− 0.161 to 0.571) 0.265 0.189 (0.035 to 0.344) 0.018* 0.073 (0.003 to 0.143) 0.043*
Amplitude of N35–P50 
(μV) 0.732 (0.418 to 1.047)  < 0.001* 0.339 (− 0.029 to 0.707) 0.039* 0.766 (0.422 to 1.111)  < 0.001*
GC-IPL average thick-
ness (μm) 0.064 (0.002 to 0.125) 0.042* 0.089 (0.040 to 0.137) 0.001* 0.04 (0.005 to 0.076) 0.028*
Macular vessel density 
 (mm−1) 0.188 (0.034 to 0.342) 0.018* 0.150 (0.046 to 0.253) 0.006* 0.011 (− 0.109 to 0.130) 0.855
Table 3.  Age-adjusted correlation analysis between macular vessel density and other parameters for glaucoma 
evaluation in the normal, early, and moderate to severe NTG groups. CI confidence interval IOP intraocular 
pressure, MD mean deviation, GC-IPL ganglion cell-inner plexiform layer. *p < 0.05.
Normal Early Moderate to severe
β (95% CI) p β (95% CI) p β (95% CI) p
IOP (mmHg)  − 0.095 (− 0.305 to 0.115) 0.367 0.367 (− 0.216 to 0.950) 0.207  − 0.268 (− 0.706 to 0.170) 0.220
MD (dB) 0.121 (− 0.693 to 0.935) 0.766 0.182 (− 0.726 to 1.089) 0.684 0.096 (− 0.194–0.385) 0.150
Central sensitivity (dB)  − 0.223 (− 0.892 to 0.447) 0.506 0.238 (− 0.332 to 0.808) 0.398 0.209 (− 0.089 to 0.388) 0.171
Amplitude of N35–P50 
(μV) 1.039 (0.418 to 1.660) 0.002* 0.634 (− 0.660 to 1.928) 0.323 0.646 (− 0.803 to 2.095) 0.369
Amplitude of P50–N95 
(μV) 0.619 (0.113 to 1.126) 0.018* 1.691 (0.520 to 2.862) 0.006* 0.113 (− 1.38 to 1.346) 0.855
GC − IPL average thickness 
(μm) 0.042 (− 0.074 to 0.158) 0.472 0.189 (0.001 to 0.377) 0.049* 0.042 (− 0.082 to 0.166) 0.486
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Discussion
It is known that the amplitude of P50–N95 is related to the function of  RGCs22–24; hence, the amplitude of 
P50–N95 is expected to play a clinical role in detecting functional changes in glaucoma. In this study, among the 
PERG parameters, only the amplitude of P50–N95 showed significant differences between-group comparisons. 
These results suggest a possible clinical utility of PERG in evaluating glaucomatous damage in patients with NTG. 
In addition, the amplitude of P50–N95 was significantly correlated with not only MD but central sensitivity in 
both the early NTG and the moderate to severe NTG group. Thus indicating that PERG may be closely related 
to the central visual function, as shown in a study that revealed an association between the lower PERG ampli-
tude and parafoveal VF  defects25. Since the average GC-IPL thickness and amplitude of P50–N95 are associated 
with the structure and function of the RGC, respectively, a significant correlation between the amplitude of 
P50–N95 and the average GC-IPL thickness in both early glaucoma and moderate to severe glaucoma groups 
Figure 1.  Age-adjusted receiver operating characteristic curves of MD, Ganglion cell-inner plexiform layer 
average thickness, the amplitude of P50–N95, and macular VD for the detection of glaucoma (a), early 
glaucoma (b), and moderate to severe glaucoma (c). MD mean deviation, OCTM_ave Ganglion cell-inner 
plexiform layer average thickness, P50–N95 the amplitude of P50–N95, VD vessel density.
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are reasonable. A similar correlation between the amplitude of P50–N95 and the average GC-IPL thickness was 
also reported in a previous  study25.
Since impairment of ocular blood flow is thought to be an important contributing factor for the development 
and progression of  glaucoma26, many studies have utilized OCTA, a non-invasive and quantitative technique 
to visualize microcirculation, for the evaluation of glaucoma  status27–29. In addition, because RGC bodies and 
dendrites are mainly located in the macula, it is expected that early glaucomatous damage can be detected in 
the macular region. Here, on correlation analyses for detecting glaucoma, macular VD showed a significant 
correlation with the amplitude of P50–N95 in the normal group and the early NTG group and with the average 
GC-IPL thickness in the early NTG group. The correlation between the amplitude of P50–N95 and the macular 
VD in the normal and early NTG groups indicate that these parameters can be employed to evaluate the RGC 
function before severe damage occurs. Whereas, the correlation between the macular VD and the average GC-
IPL thickness only in the early NTG group suggests a possible clinical utility of OCTA in assessing the early 
glaucoma status. However, since the statistical significance was marginal, this result should be interpreted with 
caution. Further studies involving a larger number of patients with NTG are needed to confirm the correlation 
between the macular VD and average GC-IPL thickness.
Considering the vascular theory for the pathogenesis of glaucoma, assessment of microvasculature in the 
macular area using OCTA may act as a sensitive indicator for detecting glaucomatous changes. In this study, 
macular VD showed a glaucoma detection ability similar to that of MD in eyes with early glaucoma (AUC values 
for macular VD and MD: 0.730 and 0.752, respectively). Previous studies have demonstrated a range of AUC 
values for the ability of macular VD (0.562–0.918) in distinguishing eyes with early glaucoma from normal 
 eyes18,30–33. Differences in scan size, OCTA specifications, glaucoma severity, and glaucoma type may have con-
tributed to the different outcomes in terms of AUC values; therefore, further studies are warranted to elucidate the 
exact role of macular VD. However, we observed a similar diagnostic ability between the macular VD and MD in 
identifying early glaucoma. These results suggest that macular OCTA can be used for the diagnosis of early NTG.
In this study, the amplitude of P50–N95 showed the lowest AUC values in detecting early glaucomatous eyes 
(AUC = 0.645). North et al. reported an AUC value of 0.787 for PERG in patients with early  glaucoma34. However, 
in other studies conducted on patients with early to moderate glaucoma, the AUC value for the amplitude of 
P50–N90 was 0.3435. Jung et al. estimated the glaucoma detection ability of PERG in patients with pre-perimetric 
and early  glaucoma36. In their study, the AUC values for the amplitude of P50–N95 in pre-perimetric glaucoma 
with and without retinal nerve fiber layer (RNFL) defects were 0.779 and 0.618, respectively. In addition, the 
AUC value for the detection of early glaucoma was 0.847. It could be likely that the type of VF impairment was 
a major contributor to the various AUC values. As proposed in a previous study conducted on patients with 
early glaucoma with paracentral scotoma, the location of VF defects should be considered when using PERG 
for evaluating the glaucoma  status25. Here, we measured the central sensitivity in all patients. Although there 
was a difference in the central sensitivity between the normal individuals and the patients with early glaucoma, 
the difference was not statistically significant (p = 0.056, Table 1). If we would have included a larger proportion 
of early glaucoma patients with paracentral scotoma, the AUC value for the amplitude of P50–N95 for early 
detection of glaucoma could have been larger than the current value. However, since we cannot treat patients 
with glaucoma for a specific type of damage in the real world, our results may reflect the actual clinical scenario. 
Further studies are needed to identify the specific types of glaucomatous damages in patients with glaucoma, 
and therefore, PERG may be a more effective test for early diagnosis of glaucoma.
In our study, macular VD showed a higher AUC value (0.804) than the amplitude of P50–N95 (0.772) for the 
detection of NTG. In the sub-group analysis, macular VD also showed a greater ability to detect early glaucoma 
than the amplitude of P50–N95 (AUC were 0.730 and 0.645, respectively). However, in the moderate to severe 
glaucoma group, the amplitude of P50–N95 showed a higher AUC value than the macular VD (0.907 and 0.876, 
respectively). Furthermore, while evaluating the detection ability of a combination of parameters in patients with 
early glaucoma, we observed a slightly higher AUC value when the amplitude of P50–N95 (0.905), instead of 
macular VD (0.898), was added to the reference parameters (MD and average thickness of GC-IPL). The results 
suggested that the role of OCTA and PERG parameters in the detection of glaucoma may vary according to its 
severity. However, in comparison to the reference parameters, the improvement in diagnostic ability on adding 
the parameters, such as the amplitude of P50–N95 and/or macular VD, was limited. Therefore, further studies 
are necessary to determine the conditions where PERG and OCTA parameters may improve the diagnostic 
power for glaucoma.
Table 4.  Age-adjusted AUC values for the detection of glaucoma. AUC area under the curve, CI confidence 
interval, MD mean density. a MD + ganglion cell-inner plexiform layer thickness. b MD + ganglion cell-inner 
plexiform layer thickness + amplitude of P50-N95+ macular vessel density.
Normal vs. all-glaucoma Normal vs. early glaucoma
AUC 95% CI AUC 95% CI
Referencea 0.951 0.914–0.988 0.894 0.820–0.969
Referencea + amplitude of P50-N95 0.954 0.919–0.990 0.905 0.836–0.974
Referencea + macular vessel density 0.951 0.912–0.990 0.898 0.822–0.974
Allb 0.960 0.927–0.993 0.918 0.854–0.983
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Few studies have compared the diagnostic ability of PERG and OCTA parameters in patients with glaucoma. 
Kurysheva et al.18 compared the diagnostic abilities of various parameters, including those related to PERG and 
OCTA, in patients with primary open-angle glaucoma. In their study, AUC values for whole image en face VD 
and the amplitude of P50–N95 for detecting early glaucoma were 0.800 and 0.893, respectively. Regarding the 
diagnostic ability of macular VD and the amplitude of P50–N95 in patients with early glaucoma, their findings 
were consistent with the results of our study. However, in their study, the diagnostic ability of the thickness of 
the ganglion cell complex and MD were lower than that of macular VD and the amplitude of P50–N95); the 
results differed from our findings. In comparison to our study, they measured VD in a different area using a dif-
ferent model of OCTA and conducted ophthalmological examinations after discontinuing topical anti-glaucoma 
medication; hence, their study findings cannot be directly compared with our results. It is well-known that 
PERG responses are affected by  IOP20,21,37. Therefore, changes in IOP after discontinuing topical anti-glaucoma 
medication may be a major confounding factor when using PERG for glaucoma evaluation. The influence of IOP 
on PERG can vary depending on whether the research was conducted in glaucoma patients with high or low 
IOP. In this study, we only included patients with NTG. The pre-treatment IOP was not significantly different 
between the normal individuals and the patients with NTG. In addition, pre-treatment IOP was not significantly 
correlated with the amplitude of P50–N95 on correlation analyses. These results suggest that PERG can be use-
ful in assessing the RGC function in NTG patients, and the correlation between PERG and OCTA parameters 
exists irrespective of the IOP status, highlighting the possible clinical utility of PERG and OCTA parameters for 
evaluating glaucomatous optic nerve damage in patients with NTG.
The main limitation of our study was its retrospective study design and small sample size. In addition, because 
the severity of glaucoma in all patients was evaluated by the VF test, it was not possible to evaluate glaucomatous 
changes that preceded the perimetric deterioration. However, perimetry is a standard method for detecting 
glaucomatous functional damage, and, in general, the severity of glaucoma is classified according to the VF test 
results; therefore, this limitation is unavoidable until a new method is developed for detecting glaucomatous 
damage. Here, we only evaluated OCT and OCTA parameters in the macular region. However, considering that 
PERG can identify the function of RGCs in the macular area, the use of only the macular parameters of OCT and 
OCTA would serve as a condition to obtain highly reliable results in identifying the association with the PERG 
parameters. Lastly, although we calculated the central sensitivity using the 24-2 VF test to measure functional 
damage in the macular area, central VF damage was not evaluated by the 10-2 VF test. Further studies involving a 
10-2 VF testing in patients with NTG are required for assessing the usefulness of PERG and OCTA in evaluating 
glaucomatous changes. Despite these limitations, we could confirm the relationship between PERG and OCTA 
parameters in patients with NTG and their potential as an adjuvant method for detecting NTG.
In conclusion, our study demonstrated significant correlations between PERG and OCTA parameters in 
patients with early NTG. The detection ability of macular VD for early glaucoma was similar to that of MD. In 
addition, there was more improvement in the detection ability on adding the amplitude of P50–N95, compared 
to macular VD, to the conventional reference methods comprising MD and average thickness of GC-IPL. The 
results indicate that PERG and OCTA parameters may play an important role in detecting early NTG. Further, 
this study demonstrates the importance of finding conditions under which the diagnostic abilities of PERG and 
OCTA parameters can be optimized for glaucoma. The diagnostic ability of macular VD was higher than that 
of the amplitude of P50–N95 in patients with early NTG, and a reverse pattern was observed in patients with 
moderate to severe NTG, indicating that the roles of PERG and OCTA parameters may vary depending on the 
severity of the glaucomatous damage.
Methods
Patients. In this retrospective study, we reviewed the medical records of patients that were examined at 
the Glaucoma Clinic of the Department of Ophthalmology of Severance Hospital, Yonsei University School of 
Medicine, Seoul, Korea between November 2017 and October 2019. The study was approved by the Institutional 
Review Board of Yonsei University Severance Hospital, Seoul, Korea (1-2019-0007) and was conducted accord-
ing to the tenets of the Declaration of Helsinki. The requirement for informed consent was waived.
The enrolled patients underwent a comprehensive ophthalmologic examination routinely performed at our 
clinic for evaluating the optic nerve status. The examination included the Snellen’s eye chart examination for best-
corrected visual acuity, Goldmann applanation tonometry for IOP, and slit-lamp bio-microscopy. RNFL defects 
and optic disc morphology were evaluated using a + 90-diopter (D) lens, red-free photography (VISUCAM 200; 
Carl Zeiss Meditec AG, Jena, Germany), and spectral-domain OCT (Cirrus 5000 HD OCT; Carl Zeiss Meditec 
AG). The VF was analyzed using standard automated perimetry (SAP) (Humphrey Field Analyzer; 24-2 Swed-
ish Interactive Threshold Algorithm; Carl Zeiss Meditec AG) to evaluate the visual function. All examinations, 
including PERG and OCTA, were performed on the same day. The patients who met the following criteria were 
included: best-correct visual acuity of 20/25 or better; the spherical equivalent of < 5 D; cylindrical refractive error 
of < 2 D; axial length of < 25.5 mm; any type of cataract with a severity grade of < 3 (Lens Opacities Classification 
System III)38; no use of systemic medications; and no pre-existing retinal or optic nerve disorders, systemic or 
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ocular conditions affecting visual function, or previous history of any intraocular surgery. The patients with a 
medical history of anti-glaucoma medication usage, before being diagnosed at our clinic, or an IOP of > 18 mmHg 
during the follow-up period were excluded from the study.
By reviewing the results of these ophthalmological examinations and medical records during the follow-up 
period, we reassessed whether the patients had NTG. In this study, NTG was defined as glaucomatous changes in 
the optic disc and related defects in the RNFL and VF, accompanied by an open angle, with a maximum untreated 
IOP of < 18 mmHg on three repeated measurements obtained at different times on separate  visits38. At least two 
of Anderson’s criteria (false-positive errors < 15%, false-negative errors < 15%, and fixation loss < 20%) had to 
be satisfied for a VF defect to be considered glaucomatous. According to Hodapp–Parrish–Anderson’s criteria, 
patients with glaucoma were classified into early or moderate to severe  groups39. Two glaucoma specialists (SYL 
and HWB) reviewed the medical records to re-evaluate the diagnosis of NTG. In cases of disagreement, another 
glaucoma specialist (CYK) determined whether NTG was present. The eye that had more severe glaucoma 
was selected. If both eyes showed normal or the same degree of glaucoma severity, the study eye was randomly 
selected.
Parameters for OCT and VF. Macular GC-IPL thickness was evaluated using a Cirrus HD OCT 512 × 128 
macular cube scan over 6 × 6  mm2 macular areas centered at the fovea. The elliptical annulus consisted of an 
inner and outer vertical diameter of 1 mm and 4 mm, respectively, and an inner and outer horizontal diameter 
of 1.2 mm and 4.8 mm, respectively. Among the various parameters (such as average, minimum, and six sectoral 
thicknesses), the average macular GC-IPL thickness was used for analyses.
The MD, PSD, and VFI measured by SAP were used as VF parameters. Additionally, to evaluate the visual 
function of the central region, we used the central sensitivity, which was calculated by averaging the sensitivity 
for 12 central cluster points that were considered to match topographically to the 4.8 mm retinal area centered 
at the fovea, as described in previous  studies40,41.
Parameters for OCTA and PERG. All participants underwent Angioplex OCT angiography on the Cirrus 
5000 HD OCT system with a 6 × 6  mm2 area pattern centered on the fovea. This examination was performed 
after pupil dilation. Participants whose images had artifacts resulting in segmentation errors or signal strength 
of < 7 were excluded. The VD of the superficial vascular plexus (from the internal limiting membrane to the 
inner plexiform layer) was calculated using a built-in software at all nine Early Treatment Diabetic Retinopathy 
Study sectors. The VD was assessed in both four inner and outer sectors and all sectors. Among these param-
eters, the VD, calculated for all sectors, was used for analyses (Fig. 2a,b).
PERGs were measured by a Neuro-ERG system (Neurosoft, Ivanovo, Russia) using a previously described 
 method36,42, that has been reported to have an excellent  reproducibility25. The examination was conducted with 
full optical correction in a room with a constant background illumination of 50 lx. The patients were made to 
sit, and two skin electrodes and two ground electrodes were placed on their lower lids and earlobes, respectively. 
A black and white checkerboard pattern with a check size of 1.81° was presented on a 24-inch LCD monitor 
(corresponding to 48° × 33° of the visual angle in the VF) held at a distance of 60 cm. The delay time of the 
LCD monitor was set to 15 ms according to the manufacturer’s recommendation to prevent the effect of the 
luminance artifact. The mean luminance of the checkerboard pattern was 100 cd/m2. The fixation point was a 
red dot at the center of the screen. The stimulus–response, an average of ≥ 100 recorded results, was band-pass 
filtered (1–50 Hz) with a sampling rate of 10,000 Hz. The responses were simultaneously measured in both eyes 
under non-dilated condition.
In this study, we used the following PERG  parameters6,43,44: (1) amplitude of N35–P50: the first positive value, 
calculated as the voltage difference between the first prominent negative value and the first prominent positive 
value, (2) amplitude of P50–N95: the first negative value, calculated as the voltage difference between the maxi-
mum peak and the subsequent trough, and (3) the implicit time (latency) for N35, P50, and N95: the time from 
the start of the checkerboard reversal to the appearance of a peak for each component.
Representative PERG results for a normal individual and a patient with NTG are presented in Fig. 2c and d, 
respectively.
Statistical analyses. Statistical analyses were performed using SAS version 9.4 software (SAS Institute 
Inc., Cary, NC, USA). Between-group comparisons were performed using the independent two-sample t-test for 
continuous variables, and the chi-square test and analysis of variance for categorical variables. Post hoc analysis 
was carried out using Scheffe’s method. The age-adjusted correlation was assessed using regression analysis. The 
ROC curve was calculated to evaluate the diagnostic power of glaucoma. To compare diagnostic ability, AUCs 
were compared using Delong’s method. Statistical significance was defined as p < 0.05.
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Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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